pubmed-article:8780629 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C0741343 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C1527121 | lld:lifeskim |
pubmed-article:8780629 | lifeskim:mentions | umls-concept:C0302995 | lld:lifeskim |
pubmed-article:8780629 | pubmed:issue | 17 | lld:pubmed |
pubmed-article:8780629 | pubmed:dateCreated | 1996-10-4 | lld:pubmed |
pubmed-article:8780629 | pubmed:abstractText | The presence of metastatic tumor cells in the axillary lymph nodes is an important factor when deciding whether or not to treat breast cancer patients with adjuvant therapy. Positron emission tomography (PET) imaging with the radiolabeled glucose analogue 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (F-18 FDG) has been used to visualize primary breast tumors as well as bone and soft-tissue metastases. | lld:pubmed |
pubmed-article:8780629 | pubmed:language | eng | lld:pubmed |
pubmed-article:8780629 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780629 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:8780629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780629 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8780629 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8780629 | pubmed:month | Sep | lld:pubmed |
pubmed-article:8780629 | pubmed:issn | 0027-8874 | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:WeberWW | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:RömerWW | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:HespRR | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:DornPP | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:GraeffHH | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:SchwaigerMM | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:ZieglerSS | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:NathrathWW | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:JänickeFF | lld:pubmed |
pubmed-article:8780629 | pubmed:author | pubmed-author:AvrilNN | lld:pubmed |
pubmed-article:8780629 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8780629 | pubmed:day | 4 | lld:pubmed |
pubmed-article:8780629 | pubmed:volume | 88 | lld:pubmed |
pubmed-article:8780629 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8780629 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8780629 | pubmed:pagination | 1204-9 | lld:pubmed |
pubmed-article:8780629 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:meshHeading | pubmed-meshheading:8780629-... | lld:pubmed |
pubmed-article:8780629 | pubmed:year | 1996 | lld:pubmed |
pubmed-article:8780629 | pubmed:articleTitle | Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. | lld:pubmed |
pubmed-article:8780629 | pubmed:affiliation | Department of Nuclear Medicine, Technische Universität München, Federal Republic of Germany. | lld:pubmed |
pubmed-article:8780629 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8780629 | lld:pubmed |